Selective loss of dopaminergic neurons is the final common pathway in Parkinson's disease. Expression of Parkin associated endothelin-receptor like receptor (Pael-R) in mouse brain was achieved by injecting adenoviral vectors carrying a modified neuron-specific promoter and Cre recombinase into the striatum. Upregulation of Pael-R in the substantia nigra pars compacta of mice by retrograde infection induced endoplasmic reticulum (ER) stress leads to death of dopaminergic neurons. The role of ER stress in dopaminergic neuronal vulnerability was highlighted by their decreased survival in mice deficient in the ubiquitin-protein ligase Parkin and the ER chaperone ORP150 (150 kDa oxygen-regulated protein). Dopamine-related toxicity was also a key factor, as a dopamine synthesis inhibitor blocked neuronal death in parkin null mice. These data suggest a model in which ER-and dopamine-related stress are major contributors to decreased viability of dopaminergic neurons in a setting relevant to Parkinson's disease.
INTRODUCTION
Though Parkinson's disease (PD) is a major contributor to disability and death in the aging population, the molecular basis of selective dopaminergic neuronal toxicity is still under investigation. Progression of the clinical syndrome associated with PD, which includes a well-characterized movement disorder, correlates closely with inexorable loss of neurons in the substantia nigra pars compacta (SNpc) (1) .
Mutations in the Parkin gene (2) have been identified in the autosomal recessive form of PD (AR-JP), a major cause of juvenile PD. Parkin is a 465 amino acid polypeptide with properties of an ubiquitin-protein ligase (E3) whose N-terminus displays homology to ubiquitin and C-terminus is comprised of two RING fingers flanking a cysteine-rich domain, termed in between RING fingers (IBR) (3 -5) . Consistent with this view, AR-JP-linked parkin mutants are defective in E3 activity (6 -8) .
A putative G protein-coupled transmembrane polypeptide, Pael Receptor [Parkin-associated endothelin-receptor like receptor (Pael-R)], has been identified as a Parkin substrate (9) . Expression of Pael-R in cultured cells results in accumulation of unfolded, insoluble and ubiquinated Pael-R in the ER, eventuating in ER stress, as indicated by upregulation of chaperones, such as GRP78/BiP, and subsequent neuronal death (10) . Overexpression of Parkin in this in vitro model resulted in removal/degradation of accumulated Pael-R and increased cell viability. The relevance of ER stress in the central nervous system to pathologic situations and normal neuronal development is suggested by induction of the unfolded protein response (UPR) in cell stress associated with cerebral ischemia (11, 12) and exposure to excitatory amino acids (13) , as well as during rapid neuronal growth in the neonatal period (14) . Salient features of the UPR include upregulation of ER chaperones, suppression of general translation, and activation of the upiquitin-proteasome pathway.
A key facet of the pathology of PD is limitation of cell loss to dopaminergic neurons, especially in the SNpc. In this context, studies of Pael-R might be especially relevant. Panneuronal expression of Pael-R in Drosophila brain caused selective, age-dependent degeneration of dopaminergic neurons (10) . Thus, increased levels of Pael-R render dopaminergic neurons vulnerable to cell death. In the current study, we have found that increased expression of Pael-R in mice in the SNpc results in neuronal death which is accentuated by suppression of Parkin (in Parkin 2/2 mice) or an ER chaperone (in Orp150 þ/2 mice). In contrast, a dopamine (DA) synthesis inhibitor had neuroprotective properties in this system. Thus, we propose a unified model for cytotoxicity in PD through which a combination of ER stress and dopamine toxicity, potentially acting in concert with mitochondrial dysfunction, result in an ascending cycle of cellular perturbation and, ultimately, death of dopaminergic neurons.
RESULTS

Retrograde and neuron-specific gene expression by adenoviral vectors in the SNpc
It was essential to develop a system with cell-specific protein expression which could be targeted to the SNpc. For this purpose, we established two adenoviral vectors in which nuclear Cre-recombinase was driven by cell-specific promoters; for neuronal expression, we employed AxS2NPNCre (abbreviated as S2NPNCre) with a modified SCG10 promoter (superior cervical ganglia neural-specific 10 protein), and for glial-specific expression, we utilized AxGFAPNCre (abbreviated as GFAPNCre) with the glial fibrillary acidic protein promoter (Fig. 1A) . When either of these adenoviral vectors was co-infected with AxCALNLEGFP (abbreviated as LoxEGFP), specific expression of EGFP occurred in neurons (with S2NPNCre) or astrocytes (with GFAPNCre) in a cell culture system (not shown). In vivoexpression studies were performed in mice by co-infecting either S2NPNCre with LoxEGFP, or GFAPNCre with LoxEGFP. Spatial limitation of gene expression was achieved by injecting viral vectors into the striatum (Fig. 1B) , resulting in expression of EGFP protein in the ipsilateral SNpc (Fig. 1C, top panel) . When S2NPNCre was injected with LoxEGFP, expression of EGFP (marking neurons) and tyrosine hydroxylase [TH; marking dopaminergic neurons in the SNpc (15)] overlapped ( Fig. 1C ; middle set of panels); quantitation of this overlap by image analysis, based on studying multiple fields, confirmed extensive coexpression of EGFP with TH (Fig. 1D ). In contrast, there was no overlap of EGFP, following injection of S2NPNCre with LoxEGFP, when immunostaining was performed to visualize GFAP (Fig. 1C , lowest set of panels and Fig. 1D ). These data indicate that co-infection of the striatum with recombinant adenoviral vectors encoding cell-specific Cre recombinase and EGFP (or other transgenes) flanked by lox P sites, leads to retrograde transport of adenovirus in the nigrostriatal system resulting in gene expression in the SNpc.
Expression of Pael-R in the SNpc activates the unfolded protein response
Using this adenoviral system, we sought to express Pael-R in the SNpc. For this purpose, an adenoviral vector was made with expression of Pael-R under control of the SCG10 promoter regulated by the LoxP system (16), AxCALNLPael-R (abbreviated as LoxPael-R; Fig. 2A ). Co-injection of the two adenoviral vectors, S2NPNCre and LoxPael-R, into the striatum increased expression of Pael-R in the SNpc (Fig. 2B , referred to as ipsilateral side). Enhanced expression of Pael-R required both vectors to be co-injected, and was specific for neurons.
Based on previous in vitro findings, increased expression of Pael-R in dopaminergic neurons might result in ER stress and diminished cell viability (9) . Control experiments were performed by co-injecting three adenoviral vectors, S2NPNCre, LoxEGFP and LoxLacZ, into the striatum on one side of the brain, referred to as contralateral (Fig. 2C, upper panels) . Expression of an ER chaperone, ORP150 (oxygen-regulated protein 150), known to increase with ER stress (11) , was assessed in neurons expressing EGFP (Fig. 2C , upper panels). ORP150 levels, assessed by Western blotting, were unchanged in the SNpc following injection of this combination of adenoviral vectors (Fig. 2D , left portion and Fig. 2E, middle panel, open bars) . Faint ORP150 staining was demonstrated in multiple cells and a much stronger signal for EGFP was observed (Fig. 2C, upper panels) . ORP150 has a putative ATPase domain and protein binding site, suggesting that it may have a chaperone-like role in maintaining ER function under stress [(17) , and see below]. In this context, we have demonstrated that overexpression of ORP150 rescues neurons from cell death mediated by ischemia (11, 12) and excitatory amino acids (13) . When S2NPNCre, LoxEGFP and LoxPael-R were injected into the striatum on the ipsilateral side of the brain (the vectors with LoxLacZ in place of LoxPael-R were injected on the contralateral side), a prominent increase in Pael-R in the SNpc (Fig, 2D , right portion) was accompanied by increased expression of ORP150 (Fig. 2C , lower panels) in Pael-R expressing neuron (labeled with EGFP). Western blotting indicated that increased expression of ER chaperones, GRP78 and ORP150, reached a maximum by 7-12 days after infection (Fig, 2D , right portion). In contrast, there was no increase in these chaperones on the contralateral side (i.e. the side where the LoxPael-R adenoviral vector was replace by a LoxLacZ vector; Fig. 2D and E). Levels of a cytoplasmic chaperone, the 70 kDa heat shock protein, remained unchanged on both sides of the brain (Fig. 2D ). These data indicate that co-infection of Fig. S1E ). Parkin homozygous mutant mice were born at the expected mendelian ratio, showed no overt abnormalities (except a slight decrease in body weight) and had normal lifespans (18, 19) . Moreover, Parkin 2/2 mice were comparable, in terms of the number of TH-positive neurons in the SNpc, compared to wild-type littermates. However, Parkin 2/2 animals displayed a slight increase in striatal dopamine content, compared with wild-type littermates (not shown).
Parkin has been shown to ubiquinate Pael-R, thereby promoting degradation of insoluble and toxic Pael-R overexpressed in cell culture systems (6) . Thus, we hypothesized that similar overexpression of Pael-R in Parkin 2/2 mice might result in severe ER stress and cell death in the SNpc. Using Parkin þ/þ and Parkin 2/2 mice, LoxPael-R was co-injected unilaterally into the striatum with LoxEGFP (as a neuronal marker) and S2NPNCre. Whereas up-regulation of Pael-R was confirmed by immunohistochemical analysis in the ipsilateral SNpc of both types of mice (white arrowheads in the lower panels of mice, (Fig. 3A and B) . Neurodegeneration in the SNpc was accompanied by loss of TH immunointensity and decreased dopamine content in the striatum (Fig. 3C and D) . mice after the overexpression of Pael-R using these methods.
To determine whether loss of TH staining in the SNpc, associated with increased expression of Pael-R, was due to neuronal death, we performed TUNEL analysis and monitored expression of a neo-epitope for activated caspase-3 (20) . Increased expression of Pael-R in the SNpc, achieved as above (by unilateral injection of S2NPNCre, LoxPael-R and LoxEGFP; the contralateral side was injected with S2NPNCre, LoxLacZ and LoxEGFP as a control), demonstrated a small increase in DNA fragmentation even in the ipsilateral SNpc of wild-type mice ( Fig. 4A and C). Increased DNA fragmentation was more striking in the ipsilateral SNpc of Parkin 2/2 mice, with maximal intensity 7 days after infection ( Fig. 4B and C) . The number of EGFP-and TUNELpositive cells is significantly increased in the SNpc of Parkin 2/2 mice ( Fig. 4B and C). It should be noted that there was a small increase in TUNEL staining on the contralateral side ( Fig. 4C) observed most consistently in caudal sections (23.4 and 23.6 from the Bregma). This might be due, at least in part, to crossed projections from the striatum to the contralateral SNpc. Pilot studies showed EGFP expression in the contralateral SNpc after unilateral injection of S2NPNCre and LoxEGFP, though this was ,5% of the EGFP expression observed in the ipsilateral SNpc (not shown). Increased expression of Pael-R in the SNpc, achieved as above, demonstrated a small increase in the intensity of activated caspase-3 staining in the ipsilateral SNpc of wild-type mice ( Since there was no apparent damage, due to experimental manipulation or other factors, in the ipsilateral striatum (this (B) Adenoviral vectors carrying either S2NPNCre, GFAPCre or LoxPael-R were injected into the striatum as described in Figure 1 , and, 7 days later, expression of Pael-R was assessed by Western blotting (upper panel), together with the levels of ß-actin as an internal control. Intensity of the corresponding bands was semi-quantitatively assessed by densitometric analysis and expressed in terms of fold-increase versus control samples where no adenovirus was injected (lower panel; n ¼ 6, mean + SD, and ÃÃ denotes P , 0.05 compared to LoxPael-R infection alone). (C) A mixture (total 2 ml) of adenoviral vectors including S2NPNCre (10 9 p.f.u.), LoxEGFP (5 Â 10 8 p.f.u.), and AxCALNLNZ (LoxLacZ; 10 9 p.f.u.) was injected unilaterally in the striatum of C57Black/6J mice (upper panels). The same mixture was injected on the contralateral side, except that LoxLacZ was replaced by LoxPael-R (10 9 p.f.u.; lower panels). Seven days later, animals were perfusion-fixed and brainstem sections were immunostained using anti-ORP150 antibody (red). Merged images with EGFP signals (green) are shown in yellow. Open boxes indicated in the far left panels are magnified in the three panels on the right. Images are representative of six repeat experiments and the marker bar indicates 200 mm. (D) S2NPNCre þ LoxLacZ (10 9 p.f.u., each) were injected unilaterally (termed ipsilateral) into the striatum, and S2NPNCre þ LoxPael-R (10 9 p.f.u., each) were injected on the contralateral side. At the indicated time points, the brainstem was removed. The SNpc was separated and Western blotting was performed using antibodies to ORP150, GRP78, HSP70 and b-actin (images are representative of six repeat experiments). (E) Expression of Pael-R (left panel), ORP150 (middle panel), and GRP78 (right panel) on the ipsilateral (open bars) or contralateral side (closed bars) was assessed by densitometric analysis and is expressed as fold-increase versus control (day 0 indicates the day of the operation without injection of adenoviral vectors (n ¼ 6, mean + S.D is shown).
ÃÃ denotes P , 0.05 by multiple comparison analysis compared to day 0 on the ipsilateral side.
Human Molecular Genetics, 2007, Vol. 16 (10 9 p.f.u.) and LoxPael-R (10 9 p.f.u.) were injected unilaterally in the striatum of either parkin þ/þ or parkin 2/2 mice, as described in Figure 1 . As a control, LoxPael-R was replaced by LoxLacZ (10 9 p.f.u.), and S2NPNCre þ LoxLacZ was injected on the contralateral side. Brains of animals were then perfusion-fixed 7 days later, and midbrain sections were stained using the Nissl method (upper two panels). One of consecutive sections was also immunostained with anti-Pael-R antibody (lower panels). Images at 23. 54
ORP150 suppresses Pael-R-mediated neuronal cell death
These observations led us to hypothesize that ER stress might trigger loss of dopaminergic neurons due to accumulation of toxic Pael-R. To gain further insight into mechanisms underlying this observation, we focused on the function of an ER chaperone, ORP150, which promotes protein folding/degradation (17) . We reasoned that if the ER stress is the cause of Pael-R-mediated dopaminergic neuron death, even in the presence of wild-type Parkin, decreased levels of ORP150 should accentuate Pael-R-induced neuronal death in the SNpc, whereas overexpression of ORP150 might be protective. Using targeted injection of adenoviral vectors (as above), Pael-R was overexpressed in the SNpc of either het- Fig. S4 upper panels; levels of ORP150 in strain-matched normal animals are also shown in lower panels). Degeneration of dopaminergic neurons was assessed by TUNEL staining and expression of activated caspase-3 ( Fig. 5A and B) , since these methods appeared to have adequate sensitivity, as shown in Figure 4 . A gene dosage effect was observed; increased levels of ORP150 afforded protection to dopaminergic neurons. Orp150 þ/2 mice, with the lowest levels of functional ORP150, displayed exaggerated damage to dopaminergic neurons; TUNEL staining and activated caspase-3 were enhanced on the ipsilateral SNpc (the side in which injection of adenoviral vectors resulted in over-expression of Pael-R; Fig. 5A and B) , whereas no significant cell death was observed on the contralateral side where LoxLacZ was expressed (data not shown). Each of these indices of neuronal stress/toxicity in this setting was decreased, in a manner dependent on the 'dose' of Orp150, when the same experiment was performed in wildtype (Orp150 þ/þ ) or mice overexpressing ORP150 (Orp150 TG mice) ( Fig. 5A and B) .
These data suggest an essential contribution of ER function in protecting neurons from lethal toxicity when Pael-R is overexpressed. According to this concept, we further reasoned that such neurons in Parkin 2/2 mice might be rescued by either expression of Parkin or ER chaperones capable of promoting protein folding/renaturation, such as GRP78. Though adenoviral expression of LacZ in neurons failed to rescue SNpc neurons from Pael-R-mediated cell death, overexpression of Parkin minimized neuronal damage (Fig. 5C) . Similarly, overexpression of GRP78 could substitute for Parkin in preventing Pael-R-mediated neuronal death in Parkin 2/2 mice. Western blot analysis of brain stem samples confirmed the expression of transfected gene products (Fig. 5C, right panel) . These data indicate that the ER chaperones, such as GRP78 and ORP150, have the capacity to relieve ER stress due to increased expression of Pael-R, thereby exerting a protective effect on dopaminergic neurons in the SNpc.
Suppression of Pael-R-mediated cell death by inhibition of dopamine synthesis
Increased dopamine content in the striatum of Parkin 2/2 mice has been noted by some investigators, though the increase is small (18, 19) . Furthermore, Pael-R has been implicated in the regulation of dopamine levels; increased Pael-R is associated with increased dopamine content in the striatum (Imai, Y. et al., manuscript in preparation). Based on these observations, we reasoned that Pael-R-mediated cell death in the SNpc of Parkin 2/2 mice might be associated with elevated levels of dopamine. Since dopamine has considerable potential toxicity (8, 22) , we further hypothesized that dopamine-derived metabolites/catabolites might contribute to loss of TH-positive (þ) neurons. To address this issue directly, we determined whether suppression of DA synthesis by AMPT, a specific inhibitor of TH (15), would have a neuroprotective effect on TH(þ) neurons overexpressing Pael-R in the SNpc of Parkin 2/2 mice. Accidental death of mice occurred in %4% of animals within 36 h after the first administration of AMPT. This might be due to the shifts of circadian temperature rhythms (23) . The systemic toxicity of AMPT was not observed at later phase. Repeated administration of AMPT over a 7 day period lowered dopamine content of the striatum to %30% of that observed in untreated controls (Supplementary Material, Fig. S5 ). Using this protocol of AMPT treatment, adenoviral vectors were injected into the striatum to increase neuronal Pael-R levels in Parkin (Fig. 6A -C) . AMPT treatment was also effective in preventing Pael-R-mediated cell death in the SNpc of Orp150 þ/2 mice, compared with animals treated with saline ( Fig. 6C) , suggesting a toxic effect of DA in ER dysfunction. These data suggest that dopamine enhances neurotoxicity associated with overexpression of Pael-R, especially in the absence of Parkin.
DISCUSSION
Our data indicate that in vivo overexpression of Pael-R in neurons of the SNpc results in enhanced ER stress, which, especially in a setting with decreased functional Parkin, targets TH-positive neurons for accentuated cytotoxicity. Whereas expression of a protein as difficult to properly fold as Pael-R has been shown to cause ER stress in a range of cell types in vitro (9), we believe that cellular vulnerability in this situation is critically exaggerated in dopaminergic neurons in vivo due to the superimposed toxicity of dopamine (10 9 p.f.u.), and LoxPael-R (10 9 p.f.u.), were injected unilaterally into the striatum of either ORP150 þ/2 (left panels), ORP150 þ/þ (middle panels) or ORP150 transgenic mice (ORP150 TG; right panels) mice. Where indicated, LoxPael-R was replaced with LoxLacZ (10 9 p.f.u.), and the latter mixture was injected on the contralateral side. Brains were then perfusion fixed at 7 (for TUNEL analysis; upper panels) and 5 (for activated caspase-3 staining; aCasp3, lower panels) days after the injection. Images were overlapped with the EGFP signal (green). In each panel, the area indicated by the arrowhead is magnified in a small inset in the lower corner. ÃÃ denotes P , 0.01 compared to ORP150 þ/þ (wild type) mice. (C) A mixture (total 2 ml) of LoxEGFP (5 Â 10 8 p.f.u.), S2NPNCre (10 9 p.f.u.), LoxPael-R (10 9 p.f.u.), and LoxLacZ (1.5 Â 10 9 p.f.u.) was injected unilaterally into the striatum of parkin 2/2 mice. On the contralateral side, LoxLacZ was replaced with either AxCMParkin (Parkin; 1.5 Â 10 9 p.f.u.) or AxCAGRP78 (GRP78; 1.5 Â 10 9 p.f.u.). Midbrain sections were stained with anti-activated caspase-3 antibody (5 days later). The percentage of activated caspase-3-positive neurons was determined on the ipsilateral (closed bars) and contralateral sides. In the latter case, data is shown following injection of the vector expressing parkin (gray bars) and GRP78 (open bars) are shown. In each case, n ¼ 6, and the mean + S.D is shown. Midbrain samples collected from parkin 2/2 mice as described in text were also subjected to Western blot analysis using either anti-b-galactosidase, anti-GRP78, anti-Parkin or anti-b-actin antibody (for an internal control). A typical example of five repeated experiments is shown.
Ã denotes P , 0.01 compared to the group injected with the vector expressing LacZ.
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Human Molecular Genetics, 2007, Vol. 16 , No. 1 (DA) itself. These data also emphasize the potential relevance of parkin targets, such as Pael-R, in addition to the aminoacyl-tRNA synthetase cofactor p38, to neurotoxicity in dopaminergic neurons (24) . The technical approach employed in our experiments, injection of adenovirus under stereotactic guidance into the striatum with selective neuronal expression of gene products, is quite unique. First, such results have been difficult to achieve in the mouse because of anatomic limitations. Though adenovirus vectors are more immunogenic than adenovirus associated virus, they still have greater merits in retrograde transfection (25) . We have taken this advantage into our experimental system, to achieve an efficient gene transfer to SNpc, where direct injection of viral vectors will be inapplicable because of anatomical limitations. Second, adenovirus infection predominately affects glia, rather than neurons. Modification of the SCG10 (superior cervical ganglion) promoter by tandem insertion of two neuron-restrictive silencers produced almost 100% expression of transgenes in neuronal cultures, and considerably lower expression in astrocytes (not shown). Coinjection of S2NPNCre with LoxEGFP into the striatum resulted in expression of transgenes in neurons of the mouse SNpc. This approach allowed us to obtain neuron-specific expression of Pael-R enabling study of its effect(s) on neuronal physiology in vivo. The proximal result of such Pael-R expression included upregulation of ER chaperones, such as GRP78 and ORP150, whereas the distal result was loss of TH-positive neurons, especially in Parkin 2/2 mice. In contrast, expression of Pael-R had no effect on the constitutively expressed form of HSP70, important for housekeeping functions in the cytoplasm (Fig. 2D ).
Several observations are consistent with the importance of ER stress as a mechanism underlying Pael-R-induced cellular toxicity. In previous studies using cultured neuroblastoma cells, Pael-R has been identified as a substrate of Parkin, an E3 ubiquitin ligase (6) . Thus, in the absence of Parkin, Pael-R may accumulate since it is not subject to efficient removal. In contrast, no detectable change of Pael-R levels has been reported in SNpc of Parkin null mice (24) . Since there is no evidence of progressive neuronal cell death in Parkin null mice, there would appear to be redundant mechanisms able to compensate for loss of Parkin under physiologic conditions. The ability of neurons to withstand ER stress imposed by expression of Pael-R is likely to be dependent on the effectiveness of the ER-stress response; higher levels of Pael-R would require a facile ER-stress response (i.e. adequate or increased levels of parkin, ORP150, GRP78 etc), whereas diminished levels of ORP150 or GRP78 would render neurons vulnerable to toxicity because of a compromised stress response. These predictions have been borne out by our experimental results. Therefore, the possible toxicity of Pael-R cannot be completely ignored, especially in pathological conditions. Increasing expression of GRP78 had a protective effect in Parkin 2/2 mice overexpressing Pael-R. Furthermore, expression of ORP150, an important factor modulating ER stress even in the presence of Parkin, modulated the toxicity of Pael-R for dopaminergic neurons; increased levels of ORP150 in transgenic mice were neuroprotective, whereas diminished levels in ORP150 in Orp150 þ/2 mice resulted in enhanced cell death (i.e. increased TUNEL staining and immunoreactivity for activated caspase-3 in the SNpc). (10 9 p.f.u.) and LoxPael-R (10 9 p.f.u.). As a control, the same vectors, with LoxPael-R replaced by LoxLacZ (10 9 p.f.u.), were injected on the contralateral side. Brains were perfusion-fixed at 7 (upper panels; for TUNEL analysis) and 5 (lower panels; staining for activated caspase-3, aCasp3) days after injection of the vectors, and were then subjected to histochemical analysis as described above. The above images were overlapped with EGFP (green). Our experimental system produced Pael-R overexpression and subsequent cell death in the SNpc of mouse, whereas no apparent cell death occurred either in the striatum or in the motor cortex (Supplementary Material, Fig. S2C ). Furthermore, we observed a neuroprotective effect of a TH inhibitor in the SNpc of mouse, suggesting that DA also contributes to Pael-R-induced cell death of dopaminergic neurons. Consistent with these results in our mouse models, studies in transgenic flies overexpressing Pael-R in most of neuronal populations also showed selective loss of dopaminergic neurons, though the mechanism of cellular degeneration is not fully understood (10) . One plausible explanation for focusing toxicity on dopaminergic neurons is the oxidative stress caused by the presence of DA and its derivatives (1) . Another possibility that DA might compromise the survival of dopaminergic neurons is a chemical inactivation of cellular proteins by addition of DA to sulfhydryl group of proteins. Recently, it has been reported that dopamine covalently modifies Parkin, a protein rich in sulfhydryl group, in dopaminergic cells, leading to increased Parkin insolubility and inactivation of its E3 function (22) . Vulnerability of Parkin to modification by DA further impairs degradation of Pael-R. Thus, even in sporadic PD, DA might interfere in the degradation of certain proteins, such as Pael-R, by the inactivation of Parkin. Collectively, these data propose a model in which a combination of ER stress and DA-related stress plays an important role in degeneration of dopaminergic neurons in sporadic PD as well as PD caused by parkin mutations.
MATERIALS AND METHODS
Targeted disruption of the mouse parkin gene
Parkin
2/2 mice were generated using standard gene targeting techniques (26) . A targeting vector was constructed with a 15.7 kb genomic DNA fragment containing exon 3 of the parkin gene (Supplementary Material, Fig. S1 ). The region containing exon 3 was replaced with a Floxed pgk-neo cassette. A DT-ApA cassette was flanked at the 5 0 -end of the homologous arm for negative selection (27) . The linearized targeting vector was transfected into E14 (129sv) ES cells. Positive clones were selected by Southern blotting, and then injected into C57Bl/6J (B6) blastocysts. Offspring harboring the targeted allele were generated by crossing chimeric mice with B6 mice. Results of such crosses were confirmed by Southern analysis.
Reverse transcription -polymerase chain reaction analysis of parkin null mice Total RNA was extracted from whole brain tissue using Isogen (Nippon gene). RT reactions containing 1 mg of total RNA were performed using the SuperScript II First-Strand Synthesis System for RT -PCR (Invitrogen). The resulting cDNA was added to PCR reactions containing 1 unit of Ex Taq DNA Polymerase (Takara) for 35 PCR cycles. PCR products were separated on a 1% agarose gel. Primers were as follows: RT primer, 5 0 -agt ttc cct tga ggt tgt gc; Primer A, 5 0 -cgt agg tcc ttc tcg acc; Primer B, 5 0 -ttg agg ttg tgc gtc cag g; Primer C, 5 0 -acc tca gag ggc tcc ata tg; and, Primer D, 5 0 -ctc tct cta cac gtc aaa cca gtg.
Construction of adenoviral vectors
Modified SCG10 (S2NP10) promoter [2 kb (28) ] and mouse GFAP promoter region (2.5 kb; kindly provided by Dr Ikenaka, National Institute for Physiological Science) were cloned into pAxAwNCre (kindly provided by Dr Saito, Tokyo University), a promoter-less cosmid vector for preparing cell type-specific Cre-recombinase expressing adenovirus ( Fig. 2A ; AxS2NPNCre and AxGFAPNCre). Human Pael-R (9) was cloned into pAxCALNLw (Takara Bio Inc., Shiga, Japan) in order to control Pael-R expression using Cre reconbinase (AxLNLPael-R). The Pael-R gene is silenced because of the presence of the staffer of the neo-resistant gene, and is activated by Cre-mediated excisional deletion of the stuffer when a sufficient amount of Cre recombinase is expressed (Fig. 3) . To prepare an adenoviral vector of parkin (AxCMParkin), the human parkin gene was cloned into pAxCMwt. Recombinant adenovirus was generating using the COS-terminal protein complex (TPC) method and the Takara adenovirus expression kit (Takara Bio Inc. 
Western blotting
Levels of Pael-R in tissue extracts were determined by Western blotting as described (9) . Mouse brain was quickly removed and placed on a cold plate. Brain slices (200 mm) were obtained at 23.5 mM from the Bregma on a vibratome. Substantia nigra was then carefully removed under guidance of a stereoscopic microscope according to the mouse brain atlas (Paxinos and Franklin, Academic Press, 1997, San Diego) using the cerebral peduncle and medial lemniscus as landmarks. Tissue extracts were prepared from SNpc in PBS containing NP-40 (1%). Proteins were separated by SDS-PAGE, and transferred to PVDF. PVDF was then incubated with antibody to either human Pael-R or ß-actin, the latter as an internal control (1000 Â dilution, Sigma, St Louis, MO, USA). Levels of chaperones in tissue extracts were determined by Western blotting, as described (30) . PVDF was incubated with either anti-human ORP150 antibody (1 mg/ml), anti-GRP78 monoclonal antibody (Stressgen, Canada; 0.2 mg/ml), or anti-HSP73 antibody (0.1 mg/ml; Stressgen). Where indicated, either anti-b-galactosideas antibody (1000 Â dilution, Sigma) or anti-Parkin antibody (1000 Â dilution, Cell Signaling Technologies Inc.) was were pretreated with a-methyl-DL-Tyrosine (AMPT) to suppress DA synthesis. AMPT-HCl (150 mg/kg, Sigma) was intra-peritoneally administrated twice per day for 5 days before injection of adenoviral vectors, as well as after the latter and until the day of sacrifice.
Assessment of neuronal death in vivo
At the indicated time points, animals were perfused with 4% paraformaldehyde under deep anesthesia, the brain was excised and coronal brain sections (14 mm) were cut on a cryostat. Sections were processed for cresyl violet staining or immunohistochemistry using either mouse anti-tyrosine hydroxylase antibody (TH; 1 mg/ml, Sigma), rabbit antihuman ORP 150 antibody [5 mg/ml (30)], rabbit anti-activated casepase-3 antibody(0.1 mg/ml, Genzyme/Teche), rabbit anti-Pael-R antibody [10 mg/ml, (9)] or goat anti-GFAP antibody (4 mg/ml. Santa Cruz Biotechnology, Santa Cruz, CA). Sections were also subjected to TUNEL staining using a commercially available kit (ApopTag, Intergen, Purchase, NY). To evaluate neuronal death in the SNpc, either Nissl or EGFP positive cells were counted in each coronal slice obtained at five different levels (23.16, 23.28, 23 .40, 23.52 and 23.64 mM from the Bregma), as described (31) by acquiring digital images using a CCD camera (Nikon, Coolscope). Cell death was semi-quantitatively assessed by counting TUNEL-positive cells/nuclei in the EGFP-positive area, and evaluating the percentage of activated caspase-3-positive cells in the population of EGFP-positive cells. Sections were analyzed using a laser scanning confocal microscope system (Leica, TCS SP2). In each case, two observers without knowledge of the experimental protocol evaluated sections and experiments were repeated at least three times. DA content in the striatum was measured in the SNpc as described (32) . In brief, striatal tissue was homogenized in solution H (0.4 M HClO 4 containing 4 mM Na 2 S 2 O 5 , 4 mM diethylenetriaminepentaacetic acid, and 5 mM 1,4-dithiothreitol). Crude tissue lysate was separated on a C-18 reversed-phase column (MCM HPLC, 4.6 mM Â 15 cm, 5 ml, ESA, Chelmsford, MA, USA), followed by electrochemical detection (Coulochem III, ESA).
Statistical analysis
Data shown represent the mean +SD Multiple group comparisons were performed by one-way ANOVA, followed by Newman-Kuels test as a post hoc analysis. Comparison between two groups was analyzed by two-tailed Student's t-test.
